Journal of Experimental & Clinical Cancer Research

Table 1 Correlation of the clinicopathological findings with LMO3 expression

From: LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling

Variable		LMO3 (n)
Variable		High	Low	P
Age	≤50 years	28	65	0.382
Age	> 50 years	35	62	0.382
Gender	Female	7	20	0.389
Gender	Male	56	107	0.389
Hepatitis history	Yes	53	116	0.263
Hepatitis history	No	10	11	0.263
Gamma-glutamytransferase	≤50(U/L)	22	50	0.605
Gamma-glutamytransferase	> 50(U/L)	40	77	0.605
Alpha-fetoprotein	≤20 ng/mL	18	49	0.185
Alpha-fetoprotein	> 20 ng/mL	44	77	0.185
Glu	≤7 mmol/L	6	11	0.793
Glu	> 7 mmol/L	55	116	0.793
Tumor multiplicity	Single	49	111	0.087
Tumor multiplicity	Multiple	14	16	0.087
Tumor satelite	Yes	19	39	0.938
Tumor satelite	No	44	88	0.938
*Tumor encapsulation	Incomplete	26	34	0.029
*Tumor encapsulation	Complete	35	93	0.029
*Tumor thrombus	Yes	22	18	< 0.001
*Tumor thrombus	No	41	109	< 0.001
Tumor differentiation	I	2	1	0.458
	II	23	49
	III	38	76
*Vascular invasion	Yes	24	27	0.014
*Vascular invasion	No	39	100	0.014
Tumor size	≤5 cm	29	71	0.199
Tumor size	> 5 cm	34	56	0.199
*TNM stage	I	31	86	0.020
	II	7	15
	III	25	25

Pearson’s χ² test was used. The bolding stands for the P-values with significant differences

Back to article page

ISSN: 1756-9966

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com